Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

77 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The stem cell-associated gene expression signature allows risk stratification in pediatric acute myeloid leukemia.
Duployez N, Marceau-Renaut A, Villenet C, Petit A, Rousseau A, Ng SWK, Paquet A, Gonzales F, Barthélémy A, Leprêtre F, Pottier N, Nelken B, Michel G, Baruchel A, Bertrand Y, Leverger G, Lapillonne H, Figeac M, Dick JE, Wang JCY, Preudhomme C, Cheok M. Duployez N, et al. Among authors: cheok m. Leukemia. 2019 Feb;33(2):348-357. doi: 10.1038/s41375-018-0227-5. Epub 2018 Aug 8. Leukemia. 2019. PMID: 30089916
Pharmacogenomics of acute leukemia.
Cheok MH, Lugthart S, Evans WE. Cheok MH, et al. Annu Rev Pharmacol Toxicol. 2006;46:317-53. doi: 10.1146/annurev.pharmtox.45.120403.100018. Annu Rev Pharmacol Toxicol. 2006. PMID: 16402908 Review.
Pharmacogenetics in acute lymphoblastic leukemia.
Cheok MH, Pottier N, Kager L, Evans WE. Cheok MH, et al. Semin Hematol. 2009 Jan;46(1):39-51. doi: 10.1053/j.seminhematol.2008.09.002. Semin Hematol. 2009. PMID: 19100367 Free PMC article. Review.
Pharmacogenomics in acute myeloid leukemia.
Roumier C, Cheok MH. Roumier C, et al. Pharmacogenomics. 2009 Nov;10(11):1839-51. doi: 10.2217/pgs.09.130. Pharmacogenomics. 2009. PMID: 19891558 Review.
Incidence and prognostic value of TET2 alterations in de novo acute myeloid leukemia achieving complete remission.
Nibourel O, Kosmider O, Cheok M, Boissel N, Renneville A, Philippe N, Dombret H, Dreyfus F, Quesnel B, Geffroy S, Quentin S, Roche-Lestienne C, Cayuela JM, Roumier C, Fenaux P, Vainchenker W, Bernard OA, Soulier J, Fontenay M, Preudhomme C. Nibourel O, et al. Among authors: cheok m. Blood. 2010 Aug 19;116(7):1132-5. doi: 10.1182/blood-2009-07-234484. Epub 2010 May 20. Blood. 2010. PMID: 20489055 Free article.
Prognostic value of minimal residual disease by real-time quantitative PCR in acute myeloid leukemia with CBFB-MYH11 rearrangement: the French experience.
Guièze R, Renneville A, Cayuela JM, Abdelali RB, Boissel N, de Botton S, Rubio MT, Mazingue F, Macintyre EA, Cheok M, Sigaux F, Fenaux P, Dombret H, Preudhomme C. Guièze R, et al. Among authors: cheok m. Leukemia. 2010 Jul;24(7):1386-8. doi: 10.1038/leu.2010.112. Epub 2010 May 27. Leukemia. 2010. PMID: 20508610 No abstract available.
Promoter polymorphisms in the β-2 adrenergic receptor are associated with drug-induced gene expression changes and response in acute lymphoblastic leukemia.
Pottier N, Paugh SW, Ding C, Pei D, Yang W, Das S, Cook EH, Pui CH, Relling MV, Cheok MH, Evans WE. Pottier N, et al. Among authors: cheok mh. Clin Pharmacol Ther. 2010 Dec;88(6):854-61. doi: 10.1038/clpt.2010.212. Epub 2010 Oct 27. Clin Pharmacol Ther. 2010. PMID: 20981007 Free PMC article. Clinical Trial.
Neurofibromatosis-1 gene deletions and mutations in de novo adult acute myeloid leukemia.
Boudry-Labis E, Roche-Lestienne C, Nibourel O, Boissel N, Terre C, Perot C, Eclache V, Gachard N, Tigaud I, Plessis G, Cuccuini W, Geffroy S, Villenet C, Figeac M, Leprêtre F, Renneville A, Cheok M, Soulier J, Dombret H, Preudhomme C; French ALFA group. Boudry-Labis E, et al. Among authors: cheok m. Am J Hematol. 2013 Apr;88(4):306-11. doi: 10.1002/ajh.23403. Epub 2013 Mar 5. Am J Hematol. 2013. PMID: 23460398 Free article.
77 results